Back to search

Phenotypeca Limited

11700555

active
Private Limited Company
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

CAWLEY HOUSE, NOTTINGHAM, NG1 7HR
Incorporated 28/11/2018

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Patrick Jean Florent

director · Since 30/09/2020

DIRECTOR

BELGIAN · BELGIUM · Age 69

Mr Simon Charles Chalk

director · Since 16/12/2020

DIRECTOR

BRITISH · ENGLAND · Age 65

Also on 4 other boards

Mr David Hanley Grinham

director · Since 15/09/2021

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 77

Professor Edward John Louis

director · Since 21/11/2022

DIRECTOR

BRITISH,AMERICAN · ENGLAND · Age 67

Also on 1 other board

Mr Johnny Mark Cordiner

director · Since 17/11/2023

DIRECTOR

BRITISH · SCOTLAND · Age 60

Also on 1 other board

Mr Christopher John Arthur Finnis

director · Since 01/03/2024

DIRECTOR

BRITISH · ENGLAND · Age 62

Also on 1 other board

Mr Ranjit Singh Bhabra

director · Since 01/04/2024

CHARTERED ACCOUNTANT

BRITISH · UNITED KINGDOM · Age 61

Also on 2 other boards

Mr Ashok Hiremath

director · Since 25/09/2025

COMPANY DIRECTOR

INDIAN · INDIA · Age 71

Persons with Significant Control

Mr Christopher John Arthur Finnis

25–50% shares
25–50% votes

British · England · Age 62

Cawley House, 149-155 Canal Street, Nottingham, NG1 7HR

Notified 28/11/2018

Former PSCs

Mr Keith Williams

Ceased 02/08/2021

CompanyRankvs 200+ SIC 72110 peers
81

Financial strength91th percentile among SIC peers · 23/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 6.61× · 20/20
Longevity8 years trading (max 15) · 8/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
200Phenotypeca Limited
80
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity8/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2025

Net Worth

£772k

Balance sheet strength

Cash

£364k

Cash in the bank

Net Current Assets

£575k

Working capital

Current Assets

£677k

Current Liabilities

£102k

Fixed Assets

£325k

Debtors

£313k

21avg. employees+1

Balance Sheet

Assets less current liabilities£900k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20256.61+£668k
20244.01-£377k
20236.95-£196k
20226.91+£453k
20213.25+£267k
20200.58—

Derived from filed accounts. Not audited figures.